CONEXEU SCIENCES INC

Conexeu Sciences surges 11.4% as earnings beat and new partnerships spark growth prospects, amid low liquidity and regulatory hurdles.

Conexeu Sciences sees a 11.37% rally, yet its private placement, fragile liquidity, and volatile price history warn investors that the stock remains speculative more than solid.

Conexeu Sciences shares tumble 9.12%, falling from a $18.79 high to $3.33 as investors await clearer earnings and R&D strategy, amid biotech volatility.